Haupt, Wolfgang
Meyer, Lukas
Wagner, Maximilian
McDonough, Rosalie
Elsayed, Sarah
Bechstein, Matthias
Schön, Gerhard
Kniep, Helge
Kemmling, Andre
Fiehler, Jens
Hanning, Uta
Broocks, Gabriel http://orcid.org/0000-0002-7575-9850
Article History
Received: 11 February 2022
Revised: 7 June 2022
Accepted: 23 June 2022
First Online: 1 July 2022
Declarations
:
: The study was conducted in accordance with the ethical guidelines of the local ethics committee (Ethikkommission der Ärztekammer Hamburg) and in accordance with the Declaration of Helsinki. Additionally, approval from local ethics committees of the participating hospitals was obtained. Only anonymized data were analyzed. The requirement of informed consent was waived by ethics committees.
: JF: research support—German Ministry of Science and Education (BMBF), German Ministry of Economy and Innovation (BMWi), German Research Foundation (DFG), European Union (EU), Hamburgische Investitions- und Förderbank (IFB), Medtronic, Microvention, Route92, Stryker. Consultant for: Acandis, Bayer, Boehringer Ingelheim, Cerenovus, Evasc Neurovascular, MD Clinicals, Medtronic, Microvention, Penumbra, Phenox, Stryker, Transverse Medical. Stock holder: Tegus Medical.
: All other authors declare no competing interests.